Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000318306-10-000058
Filing Date
2010-08-16
Accepted
2010-08-16 16:43:34
Documents
5
Period of Report
2010-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10Q a10q-063010.htm 10-Q 706678
2 CEO CERTIFICATION ex_31-1.htm EX-31.1 17904
3 CFO CERTIFICATION ex_31-2.htm EX-31.2 17921
4 CEO CERTIFICATION ex_32-1.htm EX-32.1 6173
5 CFO CERTIFICATION ex_32-2.htm EX-32.2 6183
  Complete submission text file 0000318306-10-000058.txt   756479
Mailing Address 2600 N STEMMONS FRWY STE 176 DALLAS TX 75207
Business Address 2600 N STEMMONS FRWY STE 176 DALLAS TX 75207 2149055100
ACCESS PHARMACEUTICALS INC (Filer) CIK: 0000318306 (see all company filings)

EIN.: 830221517 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-15771 | Film No.: 101020395
SIC: 2834 Pharmaceutical Preparations